Working... Menu
Trial record 1 of 4 for:    esbriet | scleroderma
Previous Study | Return to List | Next Study

Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate (SLSIII)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03221257
Recruitment Status : Recruiting
First Posted : July 18, 2017
Last Update Posted : August 12, 2019
University of Michigan
Genentech, Inc.
University of California, Los Angeles
Information provided by (Responsible Party):
Michael Roth, University of California, Los Angeles

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2021
  Estimated Study Completion Date : August 2021